BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27815935)

  • 1. Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.
    Lazarus JV; Sperle I; Spina A; Rockstroh JK
    Croat Med J; 2016 Oct; 57(5):442-456. PubMed ID: 27815935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B and C surveillance and screening programmes in the non-EU/EEA Member States of the WHO European Region: survey findings from 10 countries, 2012.
    Mozalevskis A; Eramova I; Safreed-Harmon K; Lazarus JV
    Euro Surveill; 2016 Jun; 21(22):. PubMed ID: 27277421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.
    Bottero J; Brouard C; Roudot-Thoraval F; Deuffic-Burban S; Hofliger P; Abergel A; Volant J; Dhumeaux D; Yazdanpanah Y;
    Liver Int; 2016 Oct; 36(10):1442-9. PubMed ID: 27043826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review.
    Mason LMK; Veldhuijzen IK; Duffell E; van Ahee A; Bunge EM; Amato-Gauci AJ; Tavoschi L
    J Viral Hepat; 2019 Dec; 26(12):1431-1453. PubMed ID: 31332919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention, testing, and treatment interventions for hepatitis B and C in refugee populations: results of a scoping review.
    Saseetharran A; Hiebert L; Gupta N; Nyirahabihirwe F; Kamali I; Ward JW
    BMC Infect Dis; 2023 Dec; 23(1):866. PubMed ID: 38071291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
    Abruzzi A; Fried B; Alikhan SB
    Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.
    Ishizaki A; Bouscaillou J; Luhmann N; Liu S; Chua R; Walsh N; Hess S; Ivanova E; Roberts T; Easterbrook P
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):696. PubMed ID: 29143609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.
    Seedat F; Hargreaves S; Nellums LB; Ouyang J; Brown M; Friedland JS
    Lancet Infect Dis; 2018 Sep; 18(9):e259-e271. PubMed ID: 29778396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013.
    Coppola N; Alessio L; Gualdieri L; Pisaturo M; Sagnelli C; Caprio N; Maffei R; Starace M; Angelillo IF; Pasquale G; Sagnelli E
    Euro Surveill; 2015; 20(35):30009. PubMed ID: 26530499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Language support for linguistic minority chronic hepatitis B/C patients: an exploratory study of availability and clinicians' perceptions of language barriers in six European countries.
    Falla AM; Veldhuijzen IK; Ahmad AA; Levi M; Richardus JH
    BMC Health Serv Res; 2017 Feb; 17(1):150. PubMed ID: 28219385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is screening for hepatitis B and hepatitis C useful in patients with recent-onset polyarthritis? The ESPOIR cohort study.
    Guennoc X; Narbonne V; Jousse-Joulin S; Devauchelle-Pensec V; Dougados M; Daurès JP; Saraux A
    J Rheumatol; 2009 Jul; 36(7):1407-13. PubMed ID: 19531755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing.
    Tucker JD; Meyers K; Best J; Kaplan K; Pendse R; Fenton KA; Andrieux-Meyer I; Figueroa C; Goicochea P; Gore C; Ishizaki A; Khwairakpam G; Miller V; Mozalevskis A; Ninburg M; Ocama P; Peeling R; Walsh N; Colombo MG; Easterbrook P
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):701. PubMed ID: 29143673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: results of a survey of end users and implementers.
    Reipold EI; Trianni A; Krakower D; Ongarello S; Roberts T; Easterbrook P; Denkinger C
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):702. PubMed ID: 29143612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign.
    Orkin C; Flanagan S; Wallis E; Ireland G; Dhairyawan R; Fox J; Nandwani R; O'Connell R; Lascar M; Bulman J; Reeves I; Palfreeman A; Foster GR; Ahmad K; Anderson J; Tong CY; Lattimore S
    HIV Med; 2016 Mar; 17(3):222-30. PubMed ID: 26919291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis B and hepatitis C infection from a population-based study in Southern India.
    Shanmugam RP; Balakrishnan S; Varadhan H; Shanmugam V
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1344-1351. PubMed ID: 29889684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
    Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
    Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development.
    Samji H; Yu A; Kuo M; Alavi M; Woods R; Alvarez M; Dore GJ; Tyndall M; Krajden M; Janjua NZ;
    J Hepatol; 2017 Nov; 67(5):909-917. PubMed ID: 28684103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.